MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    The Complexity of Parkinson Disease Medication Regimens May Factor into Treatment Decisions: Results of a PMD Alliance Survey

    J. Farmer, C. Goas, J. Rivera, A. Mitchell, A. Merriam, N. Crouse, A. Formella (Pennington, USA)

    Objective: Identify factors affecting PwPD and CP communications with HCPs regarding dyskinesia and OFF episodes. Background: Managing Parkinson Disease (PD) requires clear and open communication…
  • 2022 International Congress

    Environmental factors and Parkinson’s disease

    Y. Babajani, M. Salari, M. Afroozian, M. Etemadifar (Tehran, Islamic Republic of Iran)

    Objective: To assess environmental factors in the development and protection of Parkinson's disease. Background: The cause of Parkinson's disease is not known, but in summarizing…
  • 2022 International Congress

    Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson’s disease: TALISMAN study rationale and protocol

    J. Janssen Daalen, M. Meinders, B. Stunnenberg, H. Groenewoud, P. Ainslie, D. Thijssen, B. Bloem (Nijmegen, Netherlands)

    Objective: This is the first study that will assess the potential impact of hypoxia-based therapy in individuals with PD on respiratory parameters and PD symptoms.…
  • 2022 International Congress

    Local Field Potential Recordings in Parkinson’s Disease at Home: A Case Series Report

    K. Martinez, V. Madrigal, N. Morelli, A. Singer (Aliso Viejo, USA)

    Objective: To report novel, real-world use of chronic local field potential (LFP) sensing in patients with Parkinson’s disease (PD) outside-of-clinic settings. Background: Recent advancements in…
  • 2022 International Congress

    The impact of COVID-19 on Parkinson’s disease: a case-controlled registry and questionnaire study

    G. Cedergren Weber, P. Odin, J. Timpka (Lund, Sweden)

    Objective: The purpose of the study was to explore how having suffered through COVID-19 affects motor, nonmotor and general health aspects of Parkinson’s disease, and…
  • 2022 International Congress

    A motor-cognitive intervention impacts daily-living gait and activity in Parkinson’s disease fallers differently than a motor intervention: analysis using a machine learning approach

    K. Cohavi, S. Del Din, E. Gazit, E. Pelosin, L. Avanzino, N. Nieuwboer, B. Bloem, A. Cereatti, U. Croce, L. Rochester, N. Giladi, J. Hausdorff, A. Mirelman (Tel Aviv Yafo, Israel)

    Objective: Applying machine learning (ML) to identify if there were clusters of daily-living gait and physical activity measures that differed among responders to the two…
  • 2022 International Congress

    Transauricular Vagus Nerve Stimulation (taVNS) for mild to moderate Parkinson’s Disease (PD)

    V. Hinson, C. Mcleod, B. Badran, H. Boger, L. Lovera, A. Phan, J. Elm, T. Turner (Charleston, USA)

    Objective: We evaluated feasibility, safety, and preliminary efficacy of taVNS for motor and non-motor symptoms in mild to moderate PD. Background: Neuronal loss in the…
  • 2022 International Congress

    Temporal Dynamic Alterations of Regional Homogeneity in Parkinson’s disease: A Resting-State fMRI Study

    T. Yuan, L. Kai, S. Wen (Beijing, China)

    Objective: We aimed to test the differences of dynamic regional homogeneity (dReHo) between PD patients and healthy controls (HCs), and explore whether dReHo can be…
  • 2022 International Congress

    To Prescribe or Not to Prescribe: Assessing the impact of Parkinson’s nurse prescribers

    A. Hand, K. Mcewan, A. Clarke, A. Bate, S. Dalkin, R. Bradford, C. Allen, K. Mcdonald, S. Mccarthy, K. Brittain (Newcastle upon Tyne, United Kingdom)

    Objective: Within the UK, after successful completion of a formally recognised programme Parkinson’s Nurse Specialists (PNS) can act as independent prescribers, and as part of…
  • 2022 International Congress

    Dopamine-independent cortical disinhibition in Parkinson’s disease

    C. Ammann, M. Dileone, C. Pagge, D. Mata-Marín, M. Matarrazzo, M. Monje, A. Sánchez-Ferro, B. Fernández-Rodríguez, C. Gasca-Salas, J. Máñez-Miró, R. Martínez-Fernández, L. Vela, F. Alonso-Frech, A. Oliviero, JA. Obeso, G. Foffani (Móstoles, Spain)

    Objective: To test the hypothesis that cortical disinhibition in Parkinson's disease is a dopamine-independent process. Background: Motor cortex alterations in Parkinson's disease are classically considered…
  • « Previous Page
  • 1
  • …
  • 266
  • 267
  • 268
  • 269
  • 270
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley